⚡ Key Takeaways
- Prior authorization is your insurer
- New 2026 CMS rules require Medicare Advantage and Medicaid Managed Care to decide standard PAs within 7 days and urgent PAs within 72 hours.
- Connecticut Public Acts 22-58 and 23-171 give CT patients additional rights including faster decisions, step-therapy exceptions, and clearer denial notices.
- Roughly 80% of denied PAs are overturned on appeal — but the vast majority of denials are never appealed.
- Peer-to-peer reviews between your doctor and the insurer
- CID external review through an Independent Review Organization overturns approximately 50% of insurer denials at no cost to the patient.
- Medicare Advantage applies PA far more aggressively than Original Medicare; many high-acuity patients choose Original Medicare + Medigap to avoid PA friction.
- A licensed CT broker checks PA requirements for all your medications and anticipated procedures before recommending any plan.
Key Takeaways
Why Prior Authorization Is the #1 Patient Frustration in 2026
What Prior Authorization Actually Is
Why Insurers Use PA (and What They Won
What Services Typically Require Prior Authorization in 2026
Common PA-Required Services (2026 CT Commercial & Medicare Advantage)
| Category | Examples | PA Required? |
|---|---|---|
| Advanced imaging | MRI, MRA, CT, CTA, PET, nuclear medicine scans | Almost always |
| Sleep studies | Polysomnography, home sleep test | Usually |
| Inpatient admissions | Any non-emergency hospital stay | Always (except emergency) |
| Specialty drugs (Tier 5) | Biologics, oncology, MS therapy, GLP-1 for diabetes | Almost always |
| High-cost brand drugs (Tier 4) | Eliquis, Ozempic, Wegovy, Trulicity, Jardiance | Often |
| Surgery (planned) | Knee/hip replacement, bariatric surgery, spine surgery | Almost always |
| Outpatient infusions | Remicade, Ocrevus, IVIG, chemotherapy | Always |
| DME over $500 | CPAP, power wheelchair, hospital bed, glucose monitors | Usually |
| Physical/occupational therapy | Beyond initial 12–20 visit allowance | Often |
| Mental health inpatient | Acute psychiatric admission, residential treatment | Almost always |
| Genetic testing | BRCA, Oncotype, whole-exome | Almost always |
| Out-of-network care | Any non-emergency service outside network | Always (when allowed) |
Sources: CT Insurance Department Consumer Guide
The PA Process Step-by-Step
- Step 1 — Order placed: Your provider orders the medication, imaging, procedure, or admission inside their electronic health record (EHR). The EHR flags PA-required services automatically based on your insurance card information.
- Step 2 — PA request submitted: A clinical staff member (nurse, medical assistant, or pharmacy tech) submits the PA to your insurer. This is done via the insurer
- Step 3 — Insurer review: The insurer
- s medical-necessity criteria. The reviewer may approve, deny, or request additional information.
- Step 4 — Decision communicated: The insurer notifies your provider (and increasingly the patient directly) of the decision. Approval comes with an authorization number that must accompany the claim. Denial includes a stated reason and your appeal rights.
- Step 5 — Service delivered: If approved, the service proceeds. If denied, the patient and provider must decide whether to appeal, modify the order, or accept the denial.
- Step 6 — Claim filed: After the service, the provider files the claim referencing the authorization number. The insurer pays per plan benefits.
- Step 7 — Appeal (if needed): The patient or provider files a written appeal within the timeframe specified in the denial letter (usually 180 days for commercial, 60 days for Medicare). If the internal appeal is denied, the patient can escalate to CID external review.
New 2026 CMS Prior Authorization Rules
- Decision timelines tighten: 7 calendar days for standard PA, 72 hours for urgent PA. Previously many plans took 14–30 days.
- Public reporting: Insurers must publish annually their PA approval rates, denial rates, and average decision turnaround time. This is a transparency revolution.
- Specific denial reasons: Insurers must include in every denial the specific clinical criterion not met, not boilerplate language like
- Electronic submission required: Insurers must accept PA requests through a standardized FHIR API (Fast Healthcare Interoperability Resources), eliminating the fax workflow that dominated for decades.
- Provider real-time access: Providers can query a patient
- s specific plan.
- Patient access: Patients can request and receive their full PA history (approved and denied) through their plan
Sources: CMS-0057-F Final Rule
Connecticut Prior Authorization Laws (PA 22-58, PA 23-171)
Sources: Connecticut PA 22-58 Full Text
Step Therapy (
Common Step Therapy Pathways (CT 2026)
| Condition | Step 1 (Required First) | Step 2 (After Step 1 Fails) |
|---|---|---|
| Type 2 diabetes | Metformin (4–8 weeks) | GLP-1 (Ozempic, Mounjaro, Trulicity) |
| Migraine prevention | Topiramate or propranolol | CGRP injectable (Aimovig, Emgality, Ajovy) |
| Rheumatoid arthritis | Methotrexate (3–6 months) | Biologic (Humira biosimilar, Enbrel) |
| Psoriasis | Topicals + methotrexate | Biologic (Stelara, Skyrizi, Cosentyx) |
| Atrial fibrillation | Warfarin | DOAC (Eliquis, Xarelto, Pradaxa) |
| Depression | Generic SSRI (sertraline, fluoxetine) | Brand SNRI or atypical (Trintellix, Auvelity) |
| Obesity (BMI 30+) | Lifestyle + metformin off-label | GLP-1 weight-loss (Wegovy, Zepbound) |
How Each Connecticut Carrier Handles PA in 2026
Prior Authorization Inside Medicare Advantage Plans
Drugs That Almost Always Require PA in 2026
- GLP-1s for weight loss: Wegovy, Zepbound, Saxenda — almost universal PA with BMI documentation, weight-loss attempts, comorbidity proof
- GLP-1s for diabetes: Ozempic, Mounjaro, Trulicity, Rybelsus — PA usually requires A1C >7.0 and failed metformin
- Biologics for autoimmune: Humira biosimilars (Yusimry, Hadlima, Amjevita), Enbrel, Stelara, Skyrizi, Cosentyx, Taltz, Cimzia, Rinvoq, Xeljanz — PA with diagnosis confirmation, lab values, prior therapy failure
- Migraine CGRPs: Aimovig, Emgality, Ajovy, Vyepti, Nurtec, Ubrelvy, Qulipta — PA with monthly migraine days documented, failed first-line preventives
- Multiple sclerosis: Ocrevus, Kesimpta, Tysabri, Mavenclad, Tecfidera — PA with neurologist documentation, MRI findings
- Hepatitis C: Mavyret, Epclusa, Vosevi — PA with viral load, fibrosis stage
- PCSK9 inhibitors: Repatha, Praluent — PA with LDL >100 on max statin, documented statin intolerance, or familial hypercholesterolemia
- Inflammatory bowel: Stelara, Skyrizi, Remicade biosimilars, Entyvio — PA with colonoscopy, failed first-line
- Oral oncology: Ibrance, Verzenio, Kisqali, Tagrisso, Imbruvica — PA with biomarker testing, oncology rationale
- Specialty allergy: Xolair, Dupixent, Nucala, Fasenra, Tezspire — PA with diagnosis, prior therapy failure
- ADHD: Vyvanse (now generic), Adderall XR, Concerta — PA limited but quantity limits and step therapy common
- Sleep apnea: CPAP/BiPAP machines — PA with sleep study results and AHI threshold met
Procedures That Almost Always Require PA
- MRI of any body part — almost universal in 2026
- CT scans (except trauma in ER) — almost universal
- PET scans — always
- Cardiac catheterization (elective) — always
- Knee replacement — always with documentation of failed conservative care, BMI documentation, imaging
- Hip replacement — same as knee
- Spine surgery (laminectomy, fusion) — always with failed conservative care, imaging, neurological findings
- Bariatric surgery — always with documented BMI threshold, comorbidities, pre-surgical evaluations, behavioral health clearance, often 6-month medically supervised diet
- Sleep studies — usually
- Genetic testing (BRCA, expanded carrier, oncotype, whole-exome) — almost always
- Inpatient psychiatric admission — always (with retro option in true emergencies)
- Residential substance use treatment — always with ASAM criteria documentation
- Out-of-state non-emergency care — always when PPO/POS allows it
- Skilled nursing facility admission (Medicare Advantage) — always
- Home health beyond initial certification period — always
- Infusion services (Remicade, Ocrevus, IVIG, monoclonal antibody) — always
What Happens When PA Is Denied
Common PA Denial Reasons Decoded
| Stated Reason | What It Actually Means | Best Response |
|---|---|---|
| Not medically necessary | Reviewer applied criteria they think you don | , |
| Step therapy not satisfied | You haven | , |
| Investigational / experimental | Insurer disputes evidence base for treatment | Submit peer-reviewed literature; involve specialist |
| Coverage exclusion | Plan contract explicitly excludes service | Limited appeal options; check if exclusion is ACA-compliant |
| Out-of-network | Provider isn | , |
| Insufficient documentation | Submitted records missing key information | Resubmit with complete chart notes, labs, imaging reports |
| Lifetime/annual limit reached | You | , |
Peer-to-Peer Reviews — How Doctors Win Approvals
The Internal Appeal Process
Connecticut External Review With the CID
Sources: CID External Review
Emergency Care and Retroactive Prior Authorization
Six Real Connecticut Prior-Auth Scenarios
Patient Checklist: Avoid a PA Disaster
- Before any new medication, ask the provider if PA is required and how long the insurer typically takes
- Before any imaging or procedure scheduled more than 7 days out, confirm PA is on file before the appointment
- Keep a running personal log of all PA approvals, denials, and authorization numbers in a single document
- Read every denial letter immediately — appeal deadlines are short
- Always ask for the specific clinical reason and medical-necessity criteria not met
- If denied, ask your provider for a peer-to-peer review BEFORE filing a formal appeal — it
- Maintain copies of all prior therapy documentation (other plans
- Save the CID phone number (800-203-3447) in your contacts in case you need consumer assistance
- When switching plans, get PA records from your prior plan — many new plans will honor an existing PA for the first 90 days under continuity-of-care rules
- For chronic medications, ask about 90-day mail-order fills which reduce PA renewal frequency
Mistakes That Get PAs Denied
- Submitting PA after the service has been delivered (most insurers refuse retroactive PA except in true emergencies)
- Provider
- Missing prior therapy documentation in step-therapy scenarios
- Wrong ICD-10 diagnosis code on the PA submission (must match the on-label indication)
- Patient ignoring denial letter until past the appeal deadline
- Not requesting peer-to-peer review when offered
- Filing internal appeal without the supporting medical records
- Failing to escalate to CID external review after internal appeal denial
- Switching insurance plans mid-treatment and not transferring PA documentation
- Assuming the appeal is hopeless — denial overturn rate on appeal is roughly 80% nationally
How We Find Your Insurance Helps
Frequently Asked Questions
Frequently Asked Questions
How long does prior authorization take in 2026?
Under new CMS rules effective January 1, 2026, Medicare Advantage and Medicaid Managed Care plans must decide standard PA requests within 7 calendar days and urgent requests within 72 hours. Connecticut Public Act 22-58 requires CT-regulated commercial insurers to decide standard PAs within 5 business days and urgent PAs within 24 hours. Self-funded employer (ERISA) plans typically take 5–14 business days for standard, 72 hours for urgent.
What can I do if my prior authorization is denied?
First, request a peer-to-peer review where your doctor speaks directly with the insurer’s medical director — these overturn 60–70% of denials within 24–48 hours. Second, file a formal internal appeal with a physician letter of medical necessity, medical records, and clinical guideline citations. Third, if the internal appeal is denied, file a free External Review with the Connecticut Insurance Department — approximately 50% of CT external reviews overturn the insurer’s denial.
Does Medicare require prior authorization?
Original Medicare (Parts A and B) requires PA only for a narrow set of services — certain DME, some hospital outpatient procedures, and select home health. Medicare Advantage plans, however, apply PA broadly to imaging, specialty drugs, knee/hip replacements, inpatient admissions, infusions, and more. As of 2026, CMS requires MA plans to align PA criteria with Original Medicare coverage standards.
What is step therapy and can I get an exception?
Step therapy requires patients to try lower-cost drugs first before the insurer pays for a more expensive prescribed drug. Connecticut Public Act 23-171 requires insurers to grant step-therapy exceptions when (a) the patient has already failed the preferred drug, (b) the preferred drug is contraindicated, (c) the patient is stable on a non-preferred drug, or (d) delay would cause irreversible harm. Insurers must decide exception requests within 72 hours or the exception is deemed granted.
Can my insurance company deny emergency care because of prior authorization?
No. Federal law (EMTALA and the ACA) prohibits insurers from requiring prior authorization for emergency room services. You may go to any ER, in or out of network, when you reasonably believe you have a medical emergency, and the insurer must cover the visit at in-network cost-sharing under the No Surprises Act. Post-stabilization care often requires PA, but hospitals handle this through their utilization review departments.
How do I file an external review with the Connecticut Insurance Department?
After exhausting internal appeals, submit the CID External Review Request Form (available at portal.ct.gov/cid) within 4 months of the final internal denial. CID forwards the case to an Independent Review Organization (IRO) within 5 business days. Standard reviews are decided within 45 days; urgent reviews within 72 hours. There is no cost to the patient, and the IRO’s decision is binding on the insurer.
Do all health plans have the same prior authorization rules?
No. Each insurer publishes its own PA list, which changes annually. Self-funded ERISA employer plans set their own rules and are not subject to Connecticut state PA reform laws. Medicare Advantage, Medicaid Managed Care, and Marketplace plans must follow new federal CMS rules effective 2026. A licensed CT broker can compare PA requirements across plans before you enroll.
Can I switch insurance plans to avoid prior authorization on my medication?
Sometimes — but be careful. Some plans have lighter PA requirements for specific drug categories, but switching mid-year can trigger NEW PA requirements with the new plan that didn’t exist with your old plan. Continuity-of-care rules require new plans to honor existing approvals for 90 days in many cases. A licensed broker should review your full medication list against every plan’s formulary and PA criteria before recommending a switch.